Equities
Health CarePharmaceuticals and Biotechnology
  • Price (NOK)5.52
  • Today's Change-0.06 / -1.08%
  • Shares traded56.80k
  • 1 Year change-76.59%
  • Beta-0.4070
Data delayed at least 15 minutes, as of Jul 09 2025.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

  • Revenue in NOK (TTM)9.67m
  • Net income in NOK-71.76m
  • Incorporated2006
  • Employees33.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Acousort AB5.27m-16.30m69.56m16.00--9.51--13.19-1.03-1.030.33430.3260.24983.5820.43310,937.50-77.17-48.79-123.73-71.44-65.39-67.00-308.98-285.720.6689--0.00---14.4020.6111.77------
Chosa Oncology AB48.77k-10.52m71.88m----4.52--1,473.83-0.2111-0.21110.00080.15360.0029--0.1009---62.97-55.65-70.75-67.69-----21,573.91-792.50---33.570.00---39.73-62.5659.93------
Strategic Partners A/S0.00-472.88k76.12m1.00--2.49-----3.43-3.430.00461.470.00----0.00-1.39-66.13-1.78-94.41-----------2.070.00------98.86------
Biovica International AB9.14m-92.90m78.20m27.00--1.82--8.56-0.9513-0.95130.09310.44180.087813.984.95319,222.20-89.25-58.22-116.90-66.49-234.92-462.09-1,016.63-1,804.161.59-596.100.0972--18.2338.8329.80---47.26--
Coegin Pharma AB0.00-24.21m90.20m1.00--4.34-----0.967-0.9670.000.78850.00----0.00-86.28-133.34-99.26-179.59------------0.00------15.00------
2cureX AB0.00-4.82m102.20m0.00--20.61-----0.2585-0.25850.000.18630.00-------61.60-45.04-81.15-49.69---44,478.89---109,947.80----0.00------88.14------
Spago Nanomedical AB (publ)2.01m-34.12m106.32m9.00--3.92--52.81-0.1002-0.10020.00580.07350.0529--14.12146,076.90-89.69-24.44-106.09-25.71-----1,694.63-3,325.49----0.00--58.85129.5223.01------
Lifecare ASA9.67m-71.76m106.36m33.00--1.20--11.00-16.93-16.930.87474.670.0972--3.11293,029.10-73.12-52.64-91.57-61.98-----752.26-277.39----0.1898---26.1036.13-103.52------
ViroGates A/S7.78m-21.47m118.60m7.00--9.33--15.25-1.95-1.950.70161.040.27080.78023.84490,100.00-74.77-54.92-87.32-63.1545.4872.98-276.13-215.483.66-18.970.3982---12.276.45-18.59------
Abera Bioscience AB0.00-772.90k120.45m5.00--13.11-----0.0453-0.04530.000.56450.00----0.00-6.24-68.96-8.13-85.65------------0.00------93.42------
IDL Diagnostics AB (publ)63.55m-46.90m124.56m22.00--1.08--1.96-0.192-0.1920.26020.47260.41717.136.152,724,546.00-30.78-29.04-33.76-31.1420.131.70-73.80-157.604.24--0.00--33.45164.6228.41--18.85--
NextCell Pharma AB10.77m-40.62m125.42m24.00--1.51--11.64-0.6061-0.60610.15470.70270.153949.194.79423,385.40-58.04-35.01-66.62-37.45-223.34-304.79-377.03-468.526.78--0.00--5.4542.54-5.40---27.06--
Klaria Pharma Holding AB (publ)11.91m-44.77m131.76m4.00--35.50--11.06-0.3273-0.29220.08430.01140.1819--5.922,808,250.00-68.37-48.20-268.00-74.06-----375.93-1,522.52---1.510.2672---73.41-11.85-33.44------
Biosergen AB0.00-18.50m133.94m2.00--2.91-----0.1056-0.10560.000.18490.00----0.00-47.93---53.83--------------0.00------29.00------
Lumito AB (publ)86.42k-49.04m138.98m10.00--1.62--1,608.24-0.1668-0.16680.00030.30460.0008-3.738.586,792.50-43.35-24.12-52.27-26.463,028.34---56,746.39-138,894.000.9001-15.420.1337-------61.08---30.66--
Dextech Medical AB0.00-4.91m144.05m1.00--5.17-----0.2506-0.25060.001.420.00----0.00-15.82-23.30-16.21-23.93------------0.00-------2.51--18.92--
Data as of Jul 09 2025. Currency figures normalised to Lifecare ASA's reporting currency: Norwegian Krone NOK

Institutional shareholders

9.41%Per cent of shares held by top holders
HolderShares% Held
Nordea Investment Management AB (Norway)as of 12 Feb 2024796.57k5.03%
Nordea Funds Ltd.as of 30 Apr 2025695.34k4.39%
Data from 30 Apr 2025 - 30 May 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.